NM_000414.4(HSD17B4):c.1192T>C (p.Ser398Pro) AND multiple conditions

Germline classification:: Benign (1 submission)
Last evaluated:: Oct 17, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000893427.10

Allele description [Variation Report for NM_000414.4(HSD17B4):c.1192T>C (p.Ser398Pro)]

NM_000414.4(HSD17B4):c.1192T>C (p.Ser398Pro)

Gene:

HSD17B4:hydroxysteroid 17-beta dehydrogenase 4 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5q23.1

Genomic location:

Preferred name:

NM_000414.4(HSD17B4):c.1192T>C (p.Ser398Pro)

HGVS:

NC_000005.10:g.119499536T>C
NG_008182.1:g.52084T>C
NM_000414.4:c.1192T>CMANE SELECT
NM_001199291.3:c.1267T>C
NM_001199292.2:c.1138T>C
NM_001292027.2:c.1120T>C
NM_001292028.2:c.772T>C
NM_001374497.1:c.1183T>C
NM_001374498.1:c.1192T>C
NM_001374499.1:c.865T>C
NM_001374500.1:c.751T>C
NM_001374501.1:c.781T>C
NM_001374502.1:c.781T>C
NM_001374503.1:c.781T>C
NP_000405.1:p.Ser398Pro
NP_001186220.1:p.Ser423Pro
NP_001186221.1:p.Ser380Pro
NP_001278956.1:p.Ser374Pro
NP_001278957.1:p.Ser258Pro
NP_001361426.1:p.Ser395Pro
NP_001361427.1:p.Ser398Pro
NP_001361428.1:p.Ser289Pro
NP_001361429.1:p.Ser251Pro
NP_001361430.1:p.Ser261Pro
NP_001361431.1:p.Ser261Pro
NP_001361432.1:p.Ser261Pro
NC_000005.9:g.118835231T>C
NM_000414.3:c.1192T>C
NR_164653.1:n.1289T>C
NR_164654.1:n.1557T>C

Protein change:

S251P

Links:

dbSNP: rs576803491

NCBI 1000 Genomes Browser:

rs576803491

Molecular consequence:

NM_000414.4:c.1192T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001199291.3:c.1267T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001199292.2:c.1138T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001292027.2:c.1120T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001292028.2:c.772T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374497.1:c.1183T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374498.1:c.1192T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374499.1:c.865T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374500.1:c.751T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374501.1:c.781T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374502.1:c.781T>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001374503.1:c.781T>C - missense variant - [Sequence Ontology: SO:0001583]
NR_164653.1:n.1289T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_164654.1:n.1557T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Bifunctional peroxisomal enzyme deficiency (DBIF)
Synonyms:: DBP DEFICIENCY; PBFE DEFICIENCY; D-bifunctional protein deficiency
Identifiers:: MONDO: MONDO:0009855; MedGen: C0342870; OMIM: 261515

Name:: Perrault syndrome
Synonyms:: Gonadal dysgenesis with auditory dysfunction, autosomal recessive inheritance
Identifiers:: MONDO: MONDO:0017312; MedGen: C0685838; Orphanet: 2855; OMIM: PS233400

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001037359	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Oct 17, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001037359

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Oct 17, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001037359.7

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 25, 2025

ClinVar

Relating variation to medicine